Neo-antigen specific cancer vaccines for acute lymphoblastic leukemia—challenges, opportunities, and future directions

Abstract Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with standard treatment consisting of intensive chemotherapy and corticosteroids. While curative in most cases, this regimen leads to significant toxicity and long-term sequelae. Recent advancements in cancer immuno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Victoria Bloch Blytt Sandstad, Signe Modvig, Morten Orebo Holmström
Formato: Artículo
Lenguaje:inglés
Publicado: Springer 2025-06-01
Colección:Cancer Immunology, Immunotherapy
Materias:
Acceso en línea:https://doi.org/10.1007/s00262-025-04107-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!